Stay updated on Pyrotinib with Letrozole in HER2+ ER+ MBC Clinical Trial
Sign up to get notified when there's something new on the Pyrotinib with Letrozole in HER2+ ER+ MBC Clinical Trial page.

Latest updates to the Pyrotinib with Letrozole in HER2+ ER+ MBC Clinical Trial page
- Check3 days agoChange DetectedThe version history shows a new revision identifier (v3.6.3) replacing the previous (v3.6.2). This indicates a backend or UI update to the page without modifying the study data.SummaryDifference0.1%

- Check10 days agoChange DetectedA new revision entry Revision: v3.6.2 was added to the study record history and the previous Revision: v3.6.0 entry was removed, updating the page's version metadata to reflect the latest revision.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedVersion history now records a Last verified timestamp and a Last known status was note, and the revision label has been updated to v3.6.0. This reflects a metadata-level update to the study record's history.SummaryDifference3%

- Check31 days agoChange DetectedA new revision entry (v3.5.5) was added to the record history, replacing the previous revision (v3.5.4). This indicates an updated version of the study record.SummaryDifference0.1%

- Check52 days agoChange DetectedA new revision entry v3.5.4 was added to the Record History, and the previous revision v3.5.3 was removed, indicating the page has been updated to the latest version.SummaryDifference0.1%

- Check74 days agoChange DetectedA system/library version label on the page footer was updated from Revision v3.5.2 to Revision v3.5.3, with no corresponding changes to the clinical trial record history or displayed study details.SummaryDifference0.1%

Stay in the know with updates to Pyrotinib with Letrozole in HER2+ ER+ MBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pyrotinib with Letrozole in HER2+ ER+ MBC Clinical Trial page.